Net Insight AB Series B
Net Insight AB (publ) provides media network solutions worldwide. The company offers Nimbra Series, including Nimbra 1000, 600, 400, 300, 204, 140, as well as Nimbra Edge datasheet and Nimbra Vision, and Nimbra Connect iT under Nimbra brand name. It also provides Aperi Series, such as Aperi 1101, 1105, SDMP, H.264, and NAT & firewall datasheets under the Aperi brand name. In addition, the company… Read more
Market Cap & Net Worth: Net Insight AB Series B (0H14)
Net Insight AB Series B (LSE:0H14) has a market capitalization of $76.57 Million (Skr858.95 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #22194 globally and #404 in its home market, demonstrating a 1.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Net Insight AB Series B's stock price Skr2.24 by its total outstanding shares 383457984 (383.46 Million).
Net Insight AB Series B Market Cap History: 2015 to 2026
Net Insight AB Series B's market capitalization history from 2015 to 2026. Data shows change from $205.77 Million to $76.57 Million (-9.18% CAGR).
Net Insight AB Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Net Insight AB Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
Net Insight AB Series B's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $294.83 Million | $503.52 Million | $37.44 Million | 0.59x | 7.87x |
| 2017 | $177.76 Million | $426.75 Million | $3.71 Million | 0.42x | 47.95x |
| 2018 | $101.95 Million | $451.58 Million | -$58.19 Million | 0.23x | N/A |
| 2019 | $78.28 Million | $448.55 Million | -$4.64 Million | 0.17x | N/A |
| 2020 | $63.37 Million | $398.95 Million | -$9.20 Million | 0.16x | N/A |
| 2021 | $226.28 Million | $380.69 Million | $23.80 Million | 0.59x | 9.51x |
| 2022 | $206.97 Million | $475.12 Million | $54.02 Million | 0.44x | 3.83x |
| 2023 | $175.70 Million | $559.37 Million | $60.10 Million | 0.31x | 2.92x |
| 2024 | $257.75 Million | $608.01 Million | $71.05 Million | 0.42x | 3.63x |
| 2025 | $132.63 Million | $521.17 Million | -$7.55 Million | 0.25x | N/A |
Competitor Companies of 0H14 by Market Capitalization
Companies near Net Insight AB Series B in the global market cap rankings as of March 19, 2026.
Key companies related to Net Insight AB Series B by market ranking:
- Suria Capital Holdings Bhd (KLSE:6521): Ranked #22185 globally with a market cap of $40.92 Million USD ( RM184.29 Million MYR).
- MIRA Pharmaceuticals, Inc. Common Stock (NASDAQ:MIRA): Ranked #22186 globally with a market cap of $40.88 Million USD.
- Corentec Co Ltd (KQ:104540): Ranked #22195 globally with a market cap of $40.80 Million USD ( ₩59.75 Billion KRW).
- CBI Co. Ltd (KQ:013720): Ranked #22196 globally with a market cap of $40.80 Million USD ( ₩59.74 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #22185 | Suria Capital Holdings Bhd | KLSE:6521 | $40.92 Million | RM1.38 |
| #22186 | MIRA Pharmaceuticals, Inc. Common Stock | NASDAQ:MIRA | $40.88 Million | $1.17 |
| #22195 | Corentec Co Ltd | KQ:104540 | $40.80 Million | ₩5880.00 |
| #22196 | CBI Co. Ltd | KQ:013720 | $40.80 Million | ₩869.00 |
Net Insight AB Series B Historical Marketcap From 2015 to 2026
Between 2015 and today, Net Insight AB Series B's market cap moved from $205.77 Million to $ 76.57 Million, with a yearly change of -9.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr76.57 Million | -42.27% |
| 2025 | Skr132.63 Million | -48.54% |
| 2024 | Skr257.75 Million | +46.70% |
| 2023 | Skr175.70 Million | -15.11% |
| 2022 | Skr206.97 Million | -8.53% |
| 2021 | Skr226.28 Million | +257.07% |
| 2020 | Skr63.37 Million | -19.04% |
| 2019 | Skr78.28 Million | -23.22% |
| 2018 | Skr101.95 Million | -42.65% |
| 2017 | Skr177.76 Million | -39.71% |
| 2016 | Skr294.83 Million | +43.28% |
| 2015 | Skr205.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Net Insight AB Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.57 Million USD |
| MoneyControl | $76.57 Million USD |
| MarketWatch | $76.57 Million USD |
| marketcap.company | $76.57 Million USD |
| Reuters | $76.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.